Pharmacoeconomics: principles and relevance to the activities of drug and therapeutics committees.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Pharmacoeconomics: principles and relevance to the activities of drug and therapeutics committees. / Hughes, D.; Hughes, D.A.; Reynolds, D.J.
Yn: Clinical Medicine, Cyfrol 9, Rhif 5, 01.10.2009, t. 490-492.
Yn: Clinical Medicine, Cyfrol 9, Rhif 5, 01.10.2009, t. 490-492.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
Hughes, D, Hughes, DA & Reynolds, DJ 2009, 'Pharmacoeconomics: principles and relevance to the activities of drug and therapeutics committees.', Clinical Medicine, cyfrol. 9, rhif 5, tt. 490-492.
APA
Hughes, D., Hughes, D. A., & Reynolds, D. J. (2009). Pharmacoeconomics: principles and relevance to the activities of drug and therapeutics committees. Clinical Medicine, 9(5), 490-492.
CBE
Hughes D, Hughes DA, Reynolds DJ. 2009. Pharmacoeconomics: principles and relevance to the activities of drug and therapeutics committees. Clinical Medicine. 9(5):490-492.
MLA
Hughes, D., D.A. Hughes a D.J. Reynolds. "Pharmacoeconomics: principles and relevance to the activities of drug and therapeutics committees.". Clinical Medicine. 2009, 9(5). 490-492.
VancouverVancouver
Hughes D, Hughes DA, Reynolds DJ. Pharmacoeconomics: principles and relevance to the activities of drug and therapeutics committees. Clinical Medicine. 2009 Hyd 1;9(5):490-492.
Author
RIS
TY - JOUR
T1 - Pharmacoeconomics: principles and relevance to the activities of drug and therapeutics committees.
AU - Hughes, D.
AU - Hughes, D.A.
AU - Reynolds, D.J.
PY - 2009/10/1
Y1 - 2009/10/1
M3 - Article
VL - 9
SP - 490
EP - 492
JO - Clinical Medicine
JF - Clinical Medicine
IS - 5
ER -